But Kiril,Look at what you have just said.....Do some research...

But Kiril,
Look at what you have just said.....

Do some research champ, start with Sommnomed (SOM). Management came from RMD, and are very very senior and smart players.

Before they even generated any revenue, they were touted as going to be the next Resmed....with a sleep apnea solution that stops snorring....via a simple mouth guard.

Well 7 years later, manufacturing plants built, distribution in place all over the world, and substantial sales now occuring....and still no buy out by RMD even though this would fit so perfectly into their suite of products, which they could easily pump out to their distribution force and multiply sales in a blink...

SOM, substantial sales now occuring, distribution in place all over the world.........ISN can achieve the same, in a much quicker timeframe......Different need and technology, more accessable, no need for manafacturing plants....ISN may take a little time, and doesnt need to be swallowed by RESMED, nor if things go as planned would ISN ever wish to have RESMED knocking at their door, but analysists have stated ISN have the ability to become a RESMED $2.68 ps, kind of company.....wouldnt that be exciting for holders??